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Abstract Mammalian liver fatty acid binding protein (L-
FABP) is a small cytosolic protein in various tissues including
liver, small intestine and kidney and is thought to play a crucial
role in intracellular fatty acid tra⁄cking and metabolism. To
better understand its tissue-speci¢c regulation during zebra¢sh
hepatogenesis, we isolated 5P-£anking sequences of the zebra¢sh
L-FABP gene and used a green £uorescent protein (GFP) trans-
genic strategy to generate liver-speci¢c transgenic zebra¢sh.
The 2.8-kb 5P-£anking sequence of zebra¢sh L-FABP gene
was su⁄cient to direct GFP expression in liver primordia, ¢rst
observed in 2 dpf embryos and then continuously to the adult
stage. This pattern of transgenic expression is consistent with
the expression pattern of the endogenous gene. F2 inheritance
rates of 42^51% in all the seven transgenic lines were consistent
with the ratio of Mendelian segregation. Further, hhex and
zXbp-1 morphants displayed a visible liver defect, which sug-
gests that it is possible to establish an in vivo system for screen-
ing genes required for liver development.
2 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The liver fatty acid binding protein (L-FABP) is a 14-kDa
cytoplasmic protein that binds long-chain fatty acids (LCFAs)
with high a⁄nity [1]. The putative functions assigned to L-
FABP include the desorption of LCFAs from the plasma
membrane to the cytoplasm, the promotion of intracellular
fatty acid (FA) di¡usion [2], the targeting of FAs to di¡erent
metabolic pathways, and protection against the cytotoxic ef-
fects of free FA [3^6]. Three FABP types have been found in
zebra¢sh organs/tissues: intestinal-type FABP (I-FABP),
brain-type FABP (B-FABP), and liver-type FABP (L-
FABP). The zebra¢sh FABPs were originally named accord-
ing to their site of initial isolation. The zebra¢sh I-FABP is
uniformly expressed throughout the intestine. The zebra¢sh B-
FABP mRNA is expressed in the periventricular gray zone of
the optic tectum of the adult zebra¢sh brain. The L-FABP is
expressed exclusively in the liver of the adult zebra¢sh [7].
To understand the regulatory networks responsible for L-
FABP gene expression in liver, one solution would be to cre-
ate a transgenic zebra¢sh line in which green £uorescent pro-
tein (GFP) is expressed in liver. Following this strategy, we
isolated a liver-speci¢c promoter region from zebra¢sh L-
FABP gene and generated germline transgenic zebra¢sh ex-
pressing the GFP reporter gene under the control of this pro-
moter region. Here we present a detailed characterization of
transgene expression in developing zebra¢sh liver. This anal-
ysis showed that the 5P-£anking sequences of the L-FABP
gene harbor all the necessary elements for speci¢cally direct-
ing GFP gene expression to the developing liver.
The study of mouse and rat L-FABP genes has previously
been used as an excellent model for understanding the mech-
anisms that determine distinct regional expression along the
gut tube, as well as within the liver [8]. Mammalian liver
development is a cumulative e¡ect of dynamic events [9^14].
In contrast to mammals, zebra¢sh organogenesis takes only a
few days to produce functional organs [15^17]. Zebra¢sh em-
bryos are external and optically clear, which allows visual
analysis of the development of internal structures and cells
in living animals [15]. Thus, our zebra¢sh transgenic lines
o¡er several advantages for the study of liver development.
In addition, to demonstrate an in vivo system allowing
rapid screening for genes interrupting liver development, we
used morpholinos (hhex-MO and zXbp-1-MO) targeting ze-
bra¢sh Hex (hhex) and Xbp-1 (zXbp-1) mRNA to produce
zebra¢sh morphants with liver phenotypes. The adult trans-
genic ¢sh may provide a convenient source of GFP-labeled
liver cells for in vitro functional analysis, and the large num-
ber of transgenic progeny (embryos) may also be used as an
expression-based mutagenesis screen where disruption of GFP
expression patterns can be observed in live embryos. Our
characterization of zebra¢sh L-FABP genes provides an entry
point for investigating these aspects.
2. Materials and methods
2.1. Fish maintenance
Adult zebra¢sh were obtained from the local aquarium store
and maintained in our own ¢sh facility with a controlled light cycle
of 14 h light/10 h dark at 28‡C. They spawned soon after the onset of
the light period, and the fertilized eggs were collected at the one-cell
stage.
2.2. Inverse polymerase chain reaction (IPCR)
For IPCR ampli¢cation, 10 Wg of zebra¢sh genomic DNA was
digested with NcoI for 16 h. The digested DNA was phenol/chloro-
form-extracted, ethanol-precipitated, and then resuspended in 100 Wl
ligation bu¡er (50 mM Tris^HCl pH 7.4, 10 mM MgCl2, 10 mM
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dithiothreitol, 1 mM adenosine triphosphate (ATP)) to reach a ¢nal
concentration of 50^100 ng/Wl. The reaction was initiated by addition
of T4 DNA ligase (Promega) to 0.1 units/Wl and allowed to proceed
for 24 h at 16‡C. The circularized DNA was then ethanol-precipi-
tated, dried, and resuspended in 50 Wl distilled water. The IPCR re-
actions were made up with 1 Wl of recircularized genomic DNA in a
¢nal volume of 50 Wl containing 1UAdv PCR bu¡er (Clontech), 0.2
mM of each dNTP, 0.25 WM of each primer and 0.5 units of Adv
DNA polymerase (Clontech). The IPCR primers (LF-1, 5P-CAA
AGA TGT GAA GCC AGT GAC AGA-3P ; LF-2, 5P-TTT AAT
GAC CTC TTC TGG CAG AGA-3P) complementary to a 450-bp
zebra¢sh expressed sequence tag (EST) (GenBank accession number
AI545956) were designed in such a way so that their extension results
in the synthesized strands polymerized in opposite directions to each
other in the initial cycle. As a ¢rst step, the samples were denatured at
95‡C for 2 min. This was followed by 35 cycles of 0.5 min denatur-
ation at 95‡C, 0.5 min primer annealing at 60‡C and 3 min extension
at 68‡C, with a ¢nal extension at 68‡C for 4 min. The 2.8-kb IPCR
product generated from zebra¢sh genomic DNA was ligated into the
pEGFP-C1 vector (Clontech). The resulting plasmid DNA was named
pLF2.8-EGFP. The proximal promoter regions were then sequenced
for veri¢cation based on the 5P-sequences from the L-FABP cDNA
sequences.
2.3. Reverse transcriptase (RT)-PCR
For RT-PCR, one-step RT-PCR (Life Technologies) was per-
formed, using total RNA from various developmental stages. L-Actin
was used as a control and was ampli¢ed in a same PCR reaction tube
for detecting L-FABP or GFP transcripts. The primers used were: L-
FABP: 5P-GCTCTA GAA TGA AGA GAT ACC AGT GTC TGT
TC-3P (forward), 5P-CCG CTC GAG TTT GTC GTG ACC CCG
GAT GTG GCT-3P (reverse); L-actin: 5P-GTC CCT GTA CGC
CTC TGG TCG-3P (forward), 5P-GCC GGA CTC ATC GTA CTC
CTG-3P (reverse). The RT-PCR program was one cycle of 50‡C for 30
min and 94‡C for 2 min, followed by PCR ampli¢cation with 35
cycles of 94‡C for 0.5 min, 57‡C for 0.5 min, 72‡C for 1 min and a
¢nal extension of one cycle at 72‡C for 7 min. The RT-PCR products
were subjected to 3% agarose gel electrophoresis. All PCRs were car-
ried out using a Perkin-Elmer/Cetus Thermocycler 9600.
2.4. Microinjection of zebra¢sh embryos and production of transgenic
zebra¢sh lines
To construct a permanent transgenic line, the vector backbone of
pLF2.8-EGFP was removed by digesting with S¢I and NotI. Digested
DNA was adjusted to 500 ng/Wl in 5 mM Tris, 0.5 mM ethylenedi-
amine tetraacetic acid (EDTA), 100 mM KCl and 0.1% phenol red.
For transient expression, an intact circular form of plasmid DNA
constructs was adjusted to 100 ng/Wl. Approximately 200 pl of
DNA solution was injected into the blastomere of early one-cell stage
embryos with a glass micropipette. At 36 h postinjection, ¢sh were
examined using £uorescence microscopy, and GFP-expressing ¢sh
were saved. Germline integrated transgenic zebra¢sh were selected
from these GFP-positive ¢sh by raising them to sexual maturity and
breeding them with wild-type ¢sh. Progeny from these ¢sh (at least
100 progeny) were screened for GFP expression and GFP-positive ¢sh
were saved for further analysis and breeding.
2.5. Morpholino injections
Morpholino antisense oligonucleotides targeted to hhex (zebra¢sh
Hex) (GenBank accession number AF131070) and zXbp-1 (zebra¢sh
Xbp-1) (GenBank accession number AF420255) gene were obtained
from Gene Tools (Corvallis, OR, USA). hhex MO sequence: 5P-GCG
CGT GCG GGT GCT GGA ATT GCA T-3P ; zXbp-1 MO sequence:
5P-CGG TCC CTG CTG TAA CTA CGA CCA T-3P. Control mor-
pholinos of hhex and zXbp-1 were designed to include four base
mutations compared to the original MO sequences.
2.6. Whole-mount in situ hybridization
The antisense digoxigenin-labeled RNA probe for the 5P-untrans-
lated region (UTR) of zebra¢sh L-FABP was produced using a DIG-
RNA labeling kit (Roche), following the manufacturer’s instructions.
In situ hybridizations were carried out on whole-mount embryos as
previously described [18,19].
2.7. Tissue sections
LF2.8-EGFP transgenic ¢sh were perfused with 4% paraformalde-
hyde, washed with phosphate-bu¡ered saline (PBS), cryoprotected in
30% sucrose, frozen in ornithine carbamoyltransferase (OCT) (Miles
Inc.) and sectioned at 15 Wm on a cryostat.
2.8. Optics
Whole-mount in situ hybridization patterns were observed with a
Zeiss Axioscope microscope. For analyzing GFP £uorescent patterns,
embryos and larvae were anesthetized with 0.05% 2-phenoxyethanol
(Sigma) and GFP expression was examined under a £uorescein iso-
thiocyanate (FITC) ¢lter on the ECLIPSE E600 microscope (Nikon)
equipped with the DXM 1200 CCD camera (Nikon). For £uorescence
imaging by confocal laser scanning microscopy (CLSM), we used a
Leica TCSNT system ¢tted to a Leica microscope with a 20U objec-
tive (Nikon). Optical sections were scanned at regular increments of
0.5^1 Wm. Three-dimensional reconstructions and rotations were com-
puted using TCSNT version 1.6.587 software (Leica).
3. Results
3.1. IPCR cloning and transient transgenic analysis of
the L-FABP gene promoter
In order to isolate a zebra¢sh liver-speci¢c promoter region,
we used the IPCR technique described in Section 2 and iso-
lated a 2.8-kb 5P-£anking region of the L-FABP gene [7]. The
pLF2.8-EGFP expression vector produced by coupling 2783
bp of 5P-£anking region of the L-FABP gene and a partial 5P-
proximal coding region to an eGFP reporter gene, was exam-
ined for its promoter activity after removal of bacterial vector
sequences. In a transient transgenic analysis, although the
number of £uorescent cells and intensity of £uorescence var-
ied a little among the transient transgenic ¢sh, GFP expres-
sion was highly speci¢c and seen almost exclusively in the liver
primordia of the embryos injected with the transgene sequence
(Table 1). In three independent experiments, 50^60% of em-
bryos were observed to have green £uorescent cells in the liver
primordia of 3 dpf larvae.
3.2. Generation of LF2.8-EGFP transgenic zebra¢sh
To con¢rm the tissue speci¢city of the L-FABP promoter
and to generate stable GFP expression in the zebra¢sh liver,
the LF2.8-EGFP construct was used to produce germline-
transmitting transgenic zebra¢sh lines. Transgenic ¢sh were
produced by microinjection of the LF2.8-EGFP construct
(after removal of bacterial vector sequences) into one-cell
Table 1
E⁄ciency of transient transgenic GFP expression in the LF2.8EGFP-injected transgenic zebra¢sh larvae at 3 dpf
Experiment number of embryos injected
(one cell stage)
number of surviving
embryos (20^30 h)
Green £uorescence
patterns in liver (%)
Green £uorescence patterns
in other regions (%)
1 225 212 135 (60%) 4 (1.9%)
2 217 198 111 (51%) 1 (0.5%)
3 209 202 119 (57%) 0 (0%)
DNA concentration of each experiment is 100 ug/ml. 200 nl of the DNA solution was injected for experiment 1, 100 nl for experiment 2, and
50 nl for experiment 3.
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stage zebra¢sh embryos. The injected embryos were examined
at 3^5 dpf by £uorescence microscopy, grouped according to
the intensity of £uorescence, raised to sexual maturity, and
screened for potential founders. The founder ¢sh were mated
to wild-type ¢sh and the £uorescence of their 3^5 day-old
progeny was examined using £uorescence microscopy. We
raised the embryos injected with the LF2.8-EGFP construct
and isolated seven transgenic founders (three male and four
female) from 268 adult ¢sh. Founder ¢sh had highly mosaic
germlines, with F1 inheritance rates ranging from 7 to 32%.
The 42^51% F2 inheritance rates seen in all the seven lines
were consistent with those expected for Mendelian segregation
and with rates described in previous reports [21^23]. The fre-
quency of germline transmission is summarized in Table 2.
3.3. The LF2.8-EGFP transgenic expression can mimic
endogenous L-FABP expression
Liver-speci¢c expression of L-FABP had been shown in
adult zebra¢sh [7]. However, no temporal and spatial expres-
sion of L-FABP had been further analyzed in zebra¢sh em-
bryonic stages. To provide additional evidence that L-FABP-
positive cells are expressed in early liver primordia formation,
we compared the expression of L-FABP with that of cerulo-
plasmin (Cp), which has recently been shown to be expressed
in zebra¢sh liver primordia [20]. At 3 dpf, the expression of L-
FABP (LF) in embryonic liver primordia was very similar to
that of ceruloplasmin (Cp) (data not shown). In order to
assess whether the transgene conferred developmental and tis-
sue-speci¢c expression, expression of L-FABP and the eGFP
transgene were compared at various developmental stages.
Total RNA was individually puri¢ed from the various stages
of embryos and from tissues of transgenic and wild-type ¢sh.
RT-PCR was performed to detect expression of the endoge-
nous L-FABP gene and the GFP transgene. L-Actin message
was also ampli¢ed as a control for the quality of the RNA. In
the developmental process of zebra¢sh, maternally supplied L-
FABP mRNA is not detected from the stages of one cell to
early embryonic stage (12 hpf stage) and the L-FABP mRNA
is ¢rst expressed in the 36 hpf embryos. Zebra¢sh L-FABP
mRNA was abundantly expressed in the liver and was not
detected in other organs/tissues including gut, heart, pancreas
and muscle (Fig. 1). Thus, the expression pattern of the
LF2.8-EGFP transgene was very similar to that of the endog-
enous L-FABP gene.
To provide additional evidence for the similarity of the
expression patterns, we performed a series of in situ hybrid-
izations in one of the LF2.8-EGFP transgenic lines at di¡er-
ent developmental stages (Fig. 2). From 12 to 30 hpf, no
signals can be detected by either in situ analysis of L-FABP
expression in wild-type embryos or by eGFP £uorescence in
transgenic embryos (data not shown). Only a few hundred
cells expressing endogenous L-FABP in ventral endoderm
near the heart chamber were faintly detected by in situ hy-
bridization in 36 hpf embryos (data not shown), while trans-
gene expression was easily seen in a group of cells near the
same region at the same stage (data not shown). This di¡er-
ence may be due to the high stability of GFP. The transcripts
were detectable around 2 dpf ¢rst in the liver primordia
(Fig. 2A) and small green £uorescent liver primordia were
also seen in the 2 dpf transgenic embryo (Fig. 2B). L-FABP
Table 2
Inheritance of LF2.8-EGFP in transgenic zebra¢sh lines
Founders Sex Inheritance of GFP expression
F1 % F2 %
LF2.8-TG1 M 42/201 21% 166/345 48%
LF2.8-TG2 M 15/225 7% 126/279 45%
LF2.8-TG3 M 41/259 16% 111/253 44%
LF2.8-TG4 F 29/266 11% 155/303 51%
LF2.8-TG5 F 61/307 20% 146/298 49%
LF2.8-TG6 F 43/151 28% 132/312 42%
LF2.8-TG7 F 55/171 32% 125/255 49%
The F1 transgenic progeny from each line were derived from single
pairs of ¢sh by crossing founder males or females to wild-type fe-
males or males. The F2 transgenic progeny from each line were de-
rived from single pairs of ¢sh by crossing F1 transgenic males or fe-
males to wild-type females or males.
LF2.8-
Fig. 1. Comparison of the developmental and tissue-speci¢c expression of the endogenous L-FABP gene in wild-type zebra¢sh and the eGFP
transgene in two transgenic lines (LF2.8-TG1 and LF2.8-TG2). RT-PCR was performed to detect message of endogenous L-FABP gene and
GFP transgene. PCR products (400 bp for EGFP and L-FABP) from transcripts of EGFP and L-FABP zebra¢sh gene were detected by RT-
PCR at the indicated developmental stages, and in the indicated tissues at 49 dpf. L-Actin (200 bp) was used as a control and was ampli¢ed in
a same PCR reaction. WC indicates the negative water control. The PCR products were con¢rmed by sequencing.
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is predominately expressed in functional liver due to its bio-
logical functions for lipid metabolism [3^6]. Zebra¢sh liver
may start its function after the stage of 2 dpf (hatchout).
Thus, weak or no GFP £uorescence can be seen in the early
stage of transgenic embryos. The liver primordia continued to
be restricted to this similar region at 3 dpf (Fig. 2C, D). The
size of the liver primordia was increased in the 4 dpf larvae
(Fig. 2E, F), and further increased in the 5 dpf larvae
(Fig. 2G, H). The 5 dpf larvae showed a similar oval shape
structure, but this was much larger than seen in the 3 and
4 dpf liver primordia. At 5 dpf the liver became an asymmet-
rical organ, and was seen at the left-hand side of the trunk
(Fig. 2I).
To estimate the size of embryonic liver, three-dimensional
images of liver structure of the 4 dpf and 5.5 dpf larvae were
obtained by confocal laser scanning microscopy (CLSM).
GFP-expressing cells were organized into an oval-shaped clus-
ter in the 4 dpf larvae (Fig. 2J) and a conical structure in the
5.5 dpf larvae (Fig. 2K). The size of the 4 dpf larval liver as
measured by CLSM was about 105 Wm in width, 200 Wm in
length and 20^75 Wm in thickness; at 5.5 dpf these values
increased to about 91 Wm in width, 320 Wm in length, and
Fig. 2. Comparison of the endogenous L-FABP expression in embryonic progeny of wild-type zebra¢sh with expression of eGFP in progeny of
the transgenic line LF2.8-TG1. Panels A, C, E, G, I, L and N show in situ hybridization to detect endogenous L-FABP. Green £uorescence
(GF) photomicrographs were obtained at various stages of transgenic zebra¢sh development (B, D, F, H, M and O). Insets in B, D, F, H, M
and O show higher magni¢cation images of the GFP-positive liver primordia. Confocal images are shown in J and K. Scale bars: 50 Wm (A^I
and L^O); 125 Wm (J, K); 50 Wm (inserts).
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45^102 Wm in thickness. A signi¢cant increase in cell number
was seen in the 6 dpf liver, and GFP-expressing cells were
reorganized into a larger conical structure (Fig. 2L, M). The
liver becomes a crescent-shaped structure at 7 dpf (Fig. 2N,
O). These results suggest that the pattern of transgenic expres-
sion is consistent with the expression pattern of the endoge-
nous genes.
The liver still showed a conical-shaped structure at 9 dpf
(Fig. 3A), similar to what was seen at 7 dpf (Fig. 2N, O).
However, the anterior end of the intestinal tube is surrounded
by the liver in 9 dpf transgenic embryos (Fig. 3B, C). The liver
becomes a crescent-shaped structure at 14 dpf (Fig. 3D, E),
and is signi¢cantly longer at this time (Fig. 3E, F). For juve-
nile and adult transgenic ¢sh, GFP expression is strong in
juvenile ¢sh at 20 dpf (Fig. 4A) and 51 dpf (Fig. 4B), and
in adult ¢sh at 96 dpf (Fig. 4C) and 120 dpf (Fig. 4D). Green
£uorescence is only observed in the liver in sagittal sections
from 51 dpf transgenic ¢sh (Fig. 4E), and individual GFP-
labeled liver cells (hepatocyte) can be clearly discerned at
higher magni¢cation (Fig. 4F). Surprisingly, GFP £uorescence
in liver is still highly detectable and there is no visible defect in
the liver after 13 months of development. In fact, seven inde-
pendent transgenic lines show continual stable transmission
and high level of GFP expression in liver and have been
maintained for over six generations.
3.4. LF2.8-EGFP transgenic zebra¢sh lines enable the rapid or
in vivo screen for genes or mutants (morphants) required
for liver development studies
In mice, gene inactivation of Hex, Xbp-1, Sek1, c-Jun and
N-myc results in an interruption of liver development [24^29].
To demonstrate that LF2.8-EGFP transgenic lines could be
used for high throughput analyses of liver mutants, and to
compare the activity of these genes involving liver formation,
morpholinos (hhex-MO and zXbp-1-MO) targeting zebra¢sh
Hex and Xbp-1 were injected into one-cell stage LF2.8-EGFP
transgenic embryos. Embryos injected with low concentration
(100 ng/Wl) of the hhex-MO solution start to show a reduced
liver phenotype with no other defects at 4 dpf (Fig. 5A, B, C).
The liver size of embryos injected with medium concentration
(400 ng/Wl) of the hhex-MO solution was signi¢cantly reduced,
and the embryos start to show di¡erent trunk defects from 4
to 6 dpf (data not shown). The liver of embryos injected with
high concentration (800 ng/Wl) of the hhex-MO solution was
barely visible at the stage of 4 dpf, and the embryos start to
show severe edema (data not shown) at the stage of 5 dpf.
There are no e¡ects on the liver of embryos injected with the
hhex control-MO (Fig. 5D, E, F). In previous studies, zebra-
¢sh Hex morphants showed phenotypes including reduced or
absent liver, and lack of digestive organ chirality [30]. In
mouse Hex mutant embryos, the liver diverticulum could be
identi¢ed in both Hexþ=3 and Hex3=3 embryos as a small
region of cells at embryonic day 9.5 (E9.5). At E13.5, a nor-
mal liver was observed in Hexþ=þ and Hexþ=3 embryos but
this organ was absent in Hex3=3 embryos, which also had
brain defects [24]. Our data are in agreement with these stud-
ies, in that initial liver speci¢cation is seen to occur in both
mouse Hex3=3 mutants and zebra¢sh hex morphants at early
stages, but liver organogenesis fails later.
In zebra¢sh Xbp-1 morphants, a reduced size of liver with a
Fig. 3. Analysis of GFP expression in the liver of larval transgenic ¢sh. A: The liver exhibited a conical shape at 9 dpf. B, C: The anterior
end of the intestinal tube is surrounded by the liver in 9 dpf transgenic larvae. B: The dissected liver and intestine in the boxed region (A) is
depicted at higher power. C: Cross-section of 9 dpf liver. D: The liver becomes a crescent-shaped structure at 14 dpf. E: The dissected liver in
the boxed region (D) is depicted at higher power. F: Sagittal section of 14 dpf liver. The liver signi¢cantly increases its length in 14 dpf ¢sh.
Scale bars: 100 Wm (A, D); 50 Wm (B, E); 100 Wm (C, F).
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signi¢cant decrease in cell population was also seen in em-
bryos injected with low concentration (200 ng/Wl) of the
zXbp-1-MO at 4 dpf (Fig. 5G, H, I). The liver size of embryos
injected with medium concentration (800 ng/Wl) of the zXBp-
1-MO solution was similar to that of embryos injected with
low concentration (200 ng/Wl) of the zXbp-1-MO solution, but
the embryos started to show low growth rate (smaller body
length) at 5 dpf (data not shown). The liver of embryos in-
jected with high concentration (1600 ng/Wl) of the zXbp-1-MO
solution was markedly reduced and the embryos showed se-
vere edema at 4 dpf (data not shown). There were no e¡ects
on the liver of embryos injected with the zXbp-1 control-MO
solution (Fig. 5J, K, L). Mice lacking Xbp-1 displayed hypo-
plastic fetal livers and hepatocyte development itself was se-
verely impaired by diminished growth rate [26]. Our data
agree in that the delayed hepatocyte growth seen in mouse
Xbp-13=3 mutants is similar to the reduced liver cell popula-
tion observed in zebra¢sh xbp-1 morphants at early stages,
followed by impared liver organogenesis at the later stages.
As shown in Table 3, injection of hhex-MO and zXbp-1-
MO resulted in dose-dependent reduction of GFP expression
in the 4 dpf LF2.8-EGFP transgenic embryos due to an in-
Fig. 4. Analysis of GFP expression in the liver of juvenile and adult transgenic ¢sh. A^D: eGFP expression is strong in the juvenile (A: 20
dpf; B: 51 dpf) and adult zebra¢sh liver (C: 96 dpf; D: 4 months). E: Sagittal cryosection of the liver from the 51 dpf transgenic ¢sh in B;
green £uorescence is only observed in the liver. F: Individual GFP-labeled liver cells (hepatocytes) were clearly seen in the liver. G: GFP ex-
pression in liver is still quite detectable and there is no visible defect in the liver after 13 months of development. Lack of green £uorescence in
a wild-type ¢sh is shown for comparison. Scale bars: 0.2 cm (A, B, E); 0.25 cm (C); 100 Wm (F); 0.5 cm (D, G).
Table 3
Hepatogenesis in hhex and zXbp-1 morphants in 4 dpf LF2.8-EGFP zebra¢sh larvae
Phenotype Control morpholino 400 ng/Wl hhex morpholino 800 ng/Wl hhex morpholino 400 ng/Wl hhex morpholino 100 ng/Wl
Normal liver 96 (95%) 2 (1%) 5 (2.5%) 34 (17%)
Reduced liver 0 (0%) 151 (75.5%) 186 (93%) 160 (80%)
Other defect 2 (2%) 22 (11%) 3 (1.5%) 2 (1%)
Dead 3 (3%) 25 (12.5%) 6 (3%) 4 (2%)
Phenotype Control morpholino 400 ng/Wl zXbp-1 morpholino 1600 ng/Wl zXbp-1 morpholino 800 ng/Wl zXbp-1 morpholino 200 ng/Wl
Normal liver 97 (97%) 3 (1.5%) 8 (4%) 61 (30.5%)
Reduced liver 0 (0%) 163 (81.5%) 178 (89%) 126 (63%)
Other defect 1 (1%) 19 (9.5%) 5 (2.5%) 4 (2%)
Dead 2 (1%) 15 (7.5%) 9 (4.5%) 9 (4.5%)
Embryos were injected with approximately 2.0 nl of the morpholino (MO) solution per embryo. Control morpholinos for hhex and zXbp-1
were designed by four base mutations compared to their original MO sequence.
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terruption of liver development. The embryos injected with
high concentration of the hhex-MO and zXbp-1-MO solution
displayed other embryonic abnormalities, which may be due
to a signi¢cant loss of liver function later. The small livers
present in the embryos injected with low concentration of the
morpholinos do not arise from a non-speci¢c developmental
delay (Fig. 5D, E, J, K). Thus, the dramatic e¡ects of size
reduction and altered shape on the morphant livers appeared
to be a result of a decrease in the cell population during liver
formation. However, complete inhibition of liver development
Fig. 5. E¡ect of zebra¢sh Hex and Xbp-1 morpholinos (hhex-MO and zXbp-1-MO) on zebra¢sh hepatogenesis. Zebra¢sh embryos were in-
jected at the one-cell stage with a low concentration (100 ng/Wl for hhex-MO; 200 ng/Wl for zXbp-1-MO) of the morpholinos complementary to
5P-proximal regions of the cDNA as described in Section 2. A^C: The 4 dpf hhex morphant. D^F: The 4 dpf hhex control-injected morphant.
A: The liver in the hhex morphant is much smaller than in hhex control-injected morphant (D). B: The hhex morphant in A is depicted at
low power. D: The liver of hhex control morphant is normal. E: The hhex control morphant in D is depicted at low power. C, F: Histological
cross-sections of 4 dpf hhex morphants and hhex control-injected embryos. C: Interrupted liver development of hhex morphants was easily
seen in the histological section. F: Small amount of hepatic tissue in the hhex morphant (C) compared with the hhex control-injected mor-
phant. G^I: The 4 dpf zXbp-1 morphant. J^L: The 4 dpf zXbp-1 control-injected morphant. G: The liver in the zXbp-1 morphant is little
smaller than in zXbp-1 control-injected morphant (J). H: The zXbp-1 morphant in G is depicted at low power. J: The liver of zXbp-1 control
morphant is normal. K: The zXbp-1 control morphant in J is depicted at low power. I, L: Histological cross-sections of the 4 dpf zXbp-1
morphant and zXbp-1 control-injected morphant. I: Interrupted liver development of zXbp-1 morphant was easily seen in the histological sec-
tion. L: Low density of liver cells in zXbp-1 morphants (I) compared with zXbp-1 control-injected embryos. Scale bars: 50 Wm (A, D, G, J);
100 Wm (C, F, I, L). OV, otic vesicle; V, ventricle.
FEBS 27043 28-2-03 Cyaan Magenta Geel Zwart
G.M. Her et al./FEBS Letters 538 (2003) 125^133 131
was not obtained. These results illustrate how LF2.8-EGFP
transgenic zebra¢sh can be used as a simple and e⁄cient tool
for isolating and analyzing genes involved in liver develop-
ment or function in zebra¢sh.
4. Discussion
Many successful studies in transgenic zebra¢sh have been
reported in the past several years [31]. In the majority of the
previous studies, transgenic zebra¢sh were generated using a
reporter gene driven by a tissue-speci¢c promoter/enhancer of
zebra¢sh origin [23,32^38] or from other species [21,39^44].
So far, none of the liver-speci¢c gene promoters in zebra¢sh
have yet been analyzed in detail, and stable transgenic lines
carrying promoters of such genes have not been reported.
Since zebra¢sh has become a popular model organism, the
generation of transgenic zebra¢sh which express a reporter
gene in speci¢c tissues or organs will undoubtedly be useful
in the study of vertebrate organogenesis. In this study, we
have isolated and characterized the L-FABP promoter region
in zebra¢sh, a gene whose expression has previously been
shown in the liver of the adult zebra¢sh [7].
We showed that an approximately 2.8-kb 5P-upstream re-
gion contains su⁄cient regulatory elements to direct liver-spe-
ci¢c expression of GFP in embryonic, larval, juvenile, and
adult zebra¢sh. This pattern of transgene expression in the
liver recapitulates that of the intact endogenous donor zebra-
¢sh L-FABP but not that of mammalian (human, rat and
mouse) L-FABP gene, which is not only active in the liver
but also in the gastrointestinal tract [8]. In virtually all seven
lines established, no positional e¡ect of the integration sites
was found. These seven independent transgenic lines show
continual stable transmission and high level of GFP expres-
sion in liver and have been maintained for over six genera-
tions. The transgenic embryos from each line displayed an
identical £uorescent liver pattern, and no variegated GFP ex-
pression was seen in any other regions of the embryos. This
presents a strategy for using the L-FABP promoter to drive
GFP in liver without a¡ecting either early embryonic liver
development or adult liver function. Thus, the results indicate
that the zebra¢sh L-FABP promoter can reliably drive report-
er gene expression in an identical manner as the endogenous
L-FABP gene in transgenic zebra¢sh. This is the ¢rst demon-
stration of transgenic zebra¢sh in which a reporter gene is
driven by a liver-speci¢c promoter.
To demonstrate the usefulness of L-FABP transgenic zebra-
¢sh in screening liver mutants, we microinjected the transgenic
zebra¢sh embryos with morpholinos targeting zebra¢sh Hex
or Xbp-1 and showed that liver phenotypes can very easily be
observed in live embryos. Thus, these lines can be used as a
rapid and e⁄cient in vivo system for screening new genes
required for liver development and as a valuable tool for
the direct identi¢cation of liver mutants in expression-based
mutagenesis screens where disruptions in GFP expression pat-
terns can be observed in live embryos. In addition, there is
increasing awareness and concern regarding the environmen-
tal e¡ects of industrial chemicals such as those involved in
water pollution. Many of these chemical compounds may be-
come potential heptatotoxins, causing tumors or having other
toxic e¡ects in liver [45^49]. Our transgenic lines will be a
useful tool in applied in vivo studies on toxic chemicals or
carcinogens which cause liver toxicity, tumor, or disease.
Eventually, zebra¢sh models of human liver disease such as
cirrhosis or even hepatocarcinogenesis may be established.
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